IN2013MU03656A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03656A
IN2013MU03656A IN3656MU2013A IN2013MU03656A IN 2013MU03656 A IN2013MU03656 A IN 2013MU03656A IN 3656MU2013 A IN3656MU2013 A IN 3656MU2013A IN 2013MU03656 A IN2013MU03656 A IN 2013MU03656A
Authority
IN
India
Prior art keywords
pharmaceutically acceptable
pharmaceutical composition
crystalline form
relates
present
Prior art date
Application number
Other languages
English (en)
Inventor
Doshi Manish Umed Mr
Ghosh Arunava Anil Mr
Mate Siddharth Ramdas Mr
Rajesh Singh R Singh Patel Mr
Priyaranjan Mohapatro Mr
Original Assignee
Umedica Lab Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Umedica Lab Pvt Ltd filed Critical Umedica Lab Pvt Ltd
Priority to IN3656MU2013 priority Critical patent/IN2013MU03656A/en
Publication of IN2013MU03656A publication Critical patent/IN2013MU03656A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN3656MU2013 2013-11-20 2013-11-20 IN2013MU03656A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3656MU2013 IN2013MU03656A (es) 2013-11-20 2013-11-20

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3656MU2013 IN2013MU03656A (es) 2013-11-20 2013-11-20

Publications (1)

Publication Number Publication Date
IN2013MU03656A true IN2013MU03656A (es) 2015-07-31

Family

ID=54397624

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3656MU2013 IN2013MU03656A (es) 2013-11-20 2013-11-20

Country Status (1)

Country Link
IN (1) IN2013MU03656A (es)

Similar Documents

Publication Publication Date Title
MX2018007704A (es) Composicion farmaceutica que comprende lenalidomida amorfa y un antioxidante.
MY191574A (en) Pharmaceutical compositions comprising meloxicam
PH12016501122A1 (en) Delayed release compositions of linaclotide
EP3082817A4 (en) Compositions for drug administration
EP2982367A4 (en) PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION CONTAINING DONEPEZIL
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
HK1222325A1 (zh) 高效的胰酶藥物組合物
ZA201703562B (en) Pharmaceutical composition for oral administration comprising taxane
HK1248544A1 (zh) 穩定的口服給藥用藥物組合物
MX2016007682A (es) Composicion farmaceutica que comprende ivabradina amorfa.
IN2013MU01985A (es)
EA201591150A1 (ru) Твердая единая форма с высоким содержанием фексофенадина и способ ее получения
EP2958594A4 (en) Pharmaceutical composition for enhanced transmucosal administration of benzodiazepines
HK1255345A1 (zh) 含有高濃度紫杉烷的用於口服給藥的藥物組合物
MX2017008983A (es) Composición farmaceútica de sulfonamida.
EP2611799A4 (en) PHARMACEUTICAL COMPOSITIONS OF LINEZOLID
MX2021003230A (es) Composiciones farmaceuticas que comprenden meloxicam.
IN2013CH04314A (es)
IN2013MU03422A (es)
IN2013MU03656A (es)
EP3326652A4 (en) Pharmaceutical composition for oral administration comprising high concentration taxane
IN2013MU01226A (es)
EP2979698A4 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
MX2014011922A (es) Composicion para el tratamiento de desordenes inflamantorios e inmunes.
IN2013MU01160A (es)